The effect of adrenergic β2 receptor agonist on paraplegia following clamping of abdominal aorta

Archives of Medical Science

Volumn 7, Issue 4, 2011, Pages 597-603

  Lee, Bok Y ^a   Al Waili, Noori ^b   Butler, Glenn ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Life Support Technology Group   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aortic clamping; Clenbuterol; Hyperemia; Paraplegia

Indexed keywords

CLENBUTEROL; DRINKING WATER;

ABDOMINAL AORTA; ANESTHESIA; ANIMAL EXPERIMENT; ANUS SPHINCTER; AORTA CLAMPING; AORTA FLOW; ARTICLE; BLADDER SPHINCTER; BLOOD FLOWMETRY; CLIP; CONTROLLED STUDY; DRUG EFFECT; FLOWMETER; HYPEREMIA; LAPAROTOMY; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; RABBIT; RATING SCALE; RENAL ARTERY;

EID: 80052597404     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.24128     Document Type: Article

References (55)

1. Szilagyi DE, Hageman JH, Smith R. Spinal cord damage in surgery of the abdominal aorta. Surgery 1978; 83: 38-56.
2. Rosenthal D. Spinal cord ischaemia after abdominal aortic operation: is it preventable? J Vasc Surg 1999; 30: 391-9.
3. Rectenwald JE, Huber TS, Martin TD. Functional outcome after thoracoabdominal aortic aneurysm repair. J Vasc Surg 2002; 35: 640-7.
4. Estrera AL, Miller CC, Huynh TT, Porat E, Safi HJ. Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair. Ann Thorac Surg 2001; 120: 224-9.
5. Murray MJ, Bower TC, Oliver WC, Werner E, Gloviczki P. Effects of cerebrospinal fluid drainage in patients undergoing thoracic and thoracoabdominal aortic surgery. J Cardiothorac Vasc Anesth 1993; 7: 266-72.
6. Grabitz K, Sandmann W, Stuhmeier K, et al. The risk of ischemic spinal cord injury in patients undergoing graft replacement for thoracoabdominal aortic aneurysms. J Vasc Surg 1996; 23: 230-40.
7. Etz CD, Luehr M, Kari FA, et al. Paraplegia after extensive thoracic and thoracoabdominal aortic aneurysm repair: does critical spinal cord ischemia occur postoperatively? J Thorac Cardiovasc Surg 2008; 135: 324-30.
8. Marsala M, Vanicky I, Galik J, Radonak J, Kundrat I, Marsala J. Panmyelic epidural cooling protects against ischemic spinal cord damage. J Surg Res 1993; 55: 21-31.
9. Laschinger JC, Owen J, Rosenbloom M, Cox JL, Kouchoukos NT. Direct noninvasive monitoring of spinal cord motor function during thoracic aortic occlusion (use of motor evoked potentials). J Vasc Surg 1988; 7: 161-71.
10. Griepp RB, Ergin MA, Galla JD. Looking for the artery of Adamkiewicz (a quest to minimize paraplegia after operations for aneurysms of the descending thoracic and thoracoabdominal aorta). J Thorac Cardiovasc Surg 1996; 112: 1202-13.
11. Safi HJ, Miller CC, Huynh TT. Distal aortic perfusion and cerebrospinal fluid drainage for thoracoabdominal and descending thoracic aortic repair (ten years of organ protection). Ann Surg 2003; 238: 372-80.
12. Lintott P, Hafez HM, Stansby G. Spinal cord complications of thoracoabdominal aneurysm surgery. Br J Surg 1998; 85: 5-15.
13. Gharagozloo F, Larson J, Dausmann MJ. Spinal cord protection during surgical procedures on the descending thoracic and thoracoabdominal aorta. Chest 1996; 109: 799-809.
14. Mauney MC, Blackbourne LH, Langenbrug SE. Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg 1995; 59: 245-52.
15. Zoli S, Roder F, Etz CD, et al. Predicting the risk of paraplegia after thoracic and thoracoabdominal aneurysm repair. Ann Thorac Surg 2010; 90: 1237-44.
16. Baba H, Tanoue Y, Maeda T, Kobayashi M, Oda S, Tominaga R. Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits. J Vasc Surg 2010; 51: 445-52.
17. Iwamoto S, Higashi A, Ueno T, Goto M, Iguro Y, Sakata R. Protective effect of sivelestat sodium hydrate (ONO-5046) on ischemic spinal cord injury. Interact Cardiovasc Thorac Surg 2009; 8: 606-9.
18. Roseborough G, Gao D, Chen L, et al. The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord. Am J Pathol 2006; 168: 1443-51.
19. Cho Y, Ueda T, Mori A, Shimizu H, Haga Y, Yozu R. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity. J Vasc Surg 2005; 42: 765-71.
20. Hsieh YC, Liang WY, Tsai SK, Wong CS. Intrathecal ketorolac pretreatment reduced spinal cord ischemic injury in rats. Anesth Analg 2005; 100: 1134-9.
21. Acher CW, Wynn MM, Hoch JR, Popic P, Archibald J, Turnipseed WD. Combined use of cerebral spinal fluid drainage and naloxone reduces the risk of paraplegia in thoracoabdominal aneurysm repair. J Vasc Surg 1994; 19: 236-46.
22. Ashkenazi A, Dixit VM. Death receptor: signaling and modulation. Science 1998; 281: 1305-8.
23. Goyagi T, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats. Anesth Analg 2006; 103: 658-63.
24. Zeman RJ, Feng Y, Peng H, Etlinger JD. Clenbuterol, a beta2-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats. Exp Neurol 1999; 159: 267-73.
25. Culmsee C, Stumm RK, Schäfer MK, Weihe E, Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 1999; 379: 33-45.
26. Barone GW, Joob AW, Flanagan TL, Dunn CE, Kron IL. The effect of hyperemia on spinal cord function after temporary thoracic aortic occlusion. J Vasc Surg 1988; 8: 535-40.
27. Rokkas CK, Sundaresan S, Shuman TA. Profound systemic hypothermia protects the spinal cord in a primate model of spinal cord ischemia. J Thorac Cardiovasc Surg 1993; 106: 1024-35.
28. Schwartz MD, Repine JE, Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 1995; 12: 434-40.
29. Shi E, Jiang X, Kazui T, et al. Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia. J Thorac Cardiovasc Surg 2007; 133: 942-8.
30. Kunihara T, Sasaki S, Shiiya N, Miyatake T, Mafune N, Yasuda K. Proinflammatory cytokines in cerebrospinal fluid in repair of thoracoabdominal aorta. Ann Thorac Surg 2001; 71: 80180-6.
31. Lacroix S, Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 1998; 70: 452-66.
32. Nakayama M, Uchimura K, Zhu RL, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998; 95: 10954-9.
33. Nagayama M, Niwa K, Nagayama T, Ross ME, Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 1999; 19: 1213-9.
34. Wisselink W, Money SR, Crockett DE, et al. Ischemia-reperfusion injury of the spinal cord: protective effect of the hydroxyl radical scavenger dimethylthiourea. J Vasc Surg 1994; 20: 444-50.
35. Moore WM, Hollier LH. The influence of severity of spinal cord ischemia in the etiology of delayed-onset paraplegia. Ann Surg 1991; 213: 427-32.
36. Lim KH, Connolly M, Rose D, et al. Prevention of reperfusion injury of the ischemic spinal cord: use of recombinant superoxide dismutase. Ann Thorac Surg 1986; 42: 282-6.
37. Wang JY, Shen J, Gao Q, et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke 2008; 39: 983-90.
38. Xing B, Chen H, Zhang M, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 2008; 39: 2362-9.
39. Hirose K, Okajima K, Taoka Y, et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 2000; 232: 272-80.
40. Ordway GA, Gambarana C, Frazer A. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol. J Pharmacol Exp Ther 1988; 247: 379-89.
41. Semkova I, Schilling M, Henrich-Noack P. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 1996; 717: 44-54.
42. Tamura A, Graham DJ, McCulloch J, Teasdale GM. Focal cerebral ischemia in the rat: regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1: 61-8.
43. Zeman RJ, Peng H, Feng Y, Song H, Liu X, Etlinger JD. Beta2-adrenoreceptor agonist-enhanced recovery of locomotor function after spinal cord injury is glutathione dependent. J Neurotrauma 2006; 23: 170-80.
44. Ping L, Xiang J, Zhao L, Yang L, Ben-Rong H, Qin F. Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide. Acta Pharmacol Sinica 2008; 29: 661-9.
45. Semkova I, Schilling M, Henrich Noack P, Rami A, Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 1996; 717: 44-54.
46. Semkova I, Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev 1999; 30: 176-88.
47. Culmsee C, Junker V, Kremers W, et al. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 2004; 35: 1197-202.
48. Junker V, Becker A, Huhne R, et al. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 2002; 446: 25-36.
49. Culmsee C, Semkova I, Krieglstein J. NGF mediates the neu - roprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int 1999; 35: 47-57.
50. Zhu Y, Culmsee C, Semkova I, Krieglstein J. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab 1998; 18: 1032-9.
51. Zhu Y, Prehn J, Culmsee C, Krieglstein J. The beta2- adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience 1999; 90: 1255-63.
52. Gleeson LC, Ryan KJ, Griffin EW, Connor TJ, Harkin A. The beta2-adrenoceptor agonist clenbuterol elicits neuro-protective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun 2010; 24: 1354-61.
53. Bai F, Peng H, Etlinger JD, Zeman RJ. Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment. Pflugers Arch 2010; 460: 657-66.
54. McNamee EN, Griffin EW, Ryan KM, et al. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 2010; 59: 37-48.
55. Luchowska E, Kloc R, Wnuk S, Olajossy B, Wielosz M, Urbañska EM. Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures. Pharmacol Rep 2008; 60: 574-7.